Core Viewpoint - Shanghai Aopumai Biotechnology Co., Ltd. plans to acquire 100% equity of Pengli Biotechnology (Shanghai) Co., Ltd. through a combination of issuing shares and cash payment, involving multiple investment partners [1][3]. Group 1: Acquisition Details - The acquisition involves multiple investment entities, including PharmaLegacy Hong Kong Limited and several limited partnerships, indicating a broad consortium of investors [1]. - The company intends to raise supporting funds by issuing shares to no more than 35 specific investors as part of this transaction [3]. Group 2: Regulatory Compliance - The transaction is in accordance with the "Major Asset Restructuring Management Measures" which stipulates that continuous purchases or sales of the same or related assets within twelve months must be cumulatively calculated [3][4]. - The assets involved in the transaction are recognized as belonging to the same or similar business scope, thus requiring inclusion in the cumulative calculation for this transaction [5]. Group 3: Financial Adjustments - The company has adjusted its capital increase plan for its subsidiary, increasing the planned investment from 20 million RMB to 5 million RMB, reflecting a strategic shift in resource allocation [4]. - The company has also made additional investments in other subsidiaries, such as a 42 million RMB increase in Suzhou Haixing Biotechnology Co., Ltd., acquiring a 30.0014% stake [4][5].

上海奥浦迈生物科技股份有限公司 董事会关于本次交易符合《上市公司重大资产重组 管理办法》第十一条、第四十三条及第四十四条 规定的说明 上海奥浦迈生物科技股份有限公司（以下简称"公司"或"上市公司"）拟 通过发行股份及支付现金方式购买 PharmaLegacy Hong Kong Limited、嘉兴汇拓企 业管理合伙企业（有限合伙） 、红杉恒辰（厦门）股权投资合伙企业（有限合伙） 、 上海景数创业投资中心（有限合伙） 、宁波梅山保税港区谷笙澎立投资合伙企业（有 、TF PL LTD.、上海高瓴辰钧股权投资合伙企业（有限合伙） 限合伙） 、杭州泰格股 权投资合伙企业（有限合伙） 、南通东证富象股权投资中心（有限合伙） 、江西济麟 鑫盛企业管理有限公司、中金启辰贰期（苏州）新兴产业股权投资基金合伙企业（有 限合伙） 、嘉兴合拓企业管理合伙企业（有限合伙） 、苏州晨岭投资合伙企业（有限 合伙） 、德州两仪幂方康健创业投资合伙企业（有限合伙） 、平阳国凯股权投资合伙 企业（有限合伙） 、苏州一元幂方医药创业投资合伙企业（有限合伙） 、武汉泰明创 业投资合伙企业（有限合伙） 、上海敬笃企业管理合伙企业（有限合伙） 、王 ...

国泰海通证券股份有限公司 关于 中科院成都信息技术股份有限公司发行股份 及支付现金购买资产并募集配套资金 暨关联交易 之部分限售股份解除限售的核查意见 独立财务顾问 （中国（上海）自由贸易试验区商城路 618 号） 签署日期：二〇二五年六月 国泰海通证券股份有限公司（以下简称"国泰海通证券"、"本独立财务顾问"） 作为中科院成都信息技术股份有限公司（以下简称"中科信息"、"上市公司"或"公 司"）发行股份及支付现金购买资产并募集配套资金暨关联交易（以下简称"本次 交易"）的独立财务顾问，根据《证券发行上市保荐业务管理办法》 《上市公司重 大资产重组管理办法》 《深圳证券交易所创业板股票上市规则》 《深圳证券交易所 上市公司自律监管指引第 2 号—创业板上市公司规范运作》等相关法律法规的 规定，对本次交易部分限售股份解除限售情况进行了审慎核查，具体核查情况如 下： 一、公司本次解除限售股份情况 （一）本次解除限售股份的发行及上市情况 管理委员会（以下简称"中国证监会"）于 2021 年 9 月 23 日出具的《关于同意中 科院成都信息技术股份有限公司向成都中科唯实仪器有限责任公司等发行股份 购买资产并募集配套资 ...

Core Viewpoint - Guangzhou Metro Design Institute Co., Ltd. plans to acquire 100% equity of Guangzhou Metro Engineering Consulting Co., Ltd. from Guangzhou Metro Group through a share issuance and raise supporting funds from no more than 35 specific investors, constituting a related party transaction but not a major asset restructuring [1][2]. Group 1: Transaction Details - The company will issue shares to purchase 100% equity of the target company, with the total transaction price set at 51,110 million yuan [27][55]. - The company aims to raise up to 15,978.58 million yuan through the issuance of shares, which will not exceed 30% of the total share capital after the transaction [31][50]. - The share issuance price is determined to be 12.15 yuan per share, which is not lower than 80% of the average trading price over the previous 120 trading days [36][35]. Group 2: Meeting and Approval Process - The company will hold the second temporary shareholders' meeting of 2025 on June 20, 2025, to discuss the transaction [4][5]. - The transaction requires approval from the shareholders' meeting, Shenzhen Stock Exchange, and registration with the China Securities Regulatory Commission [2][28]. - The meeting will adopt a combination of on-site and online voting methods, with specific voting times outlined [6][16]. Group 3: Performance Commitment and Compensation - Guangzhou Metro Group commits to a net profit of no less than 3,527.77 million yuan, 3,803.46 million yuan, and 4,061.02 million yuan for the years 2025, 2026, and 2027, respectively [58]. - If the actual net profit falls short of the committed amount, Guangzhou Metro Group will compensate the company [57][60]. - The performance commitment period spans three accounting years following the completion of the transaction [58].

深圳至正高分子材料股份有限公司董事会 关于本次交易符合《上市公司重大资产重组管理办法》第十 一条、第四十三条和第四十四条规定的说明 （四）本次交易所涉及的资产权属清晰，在相关法律程序和先决条件得到适 当履行的情形下，资产过户或者转移不存在法律障碍，相关债权债务处理合法； （五）本次交易有利于上市公司增强持续经营能力，不存在可能导致上市公 司重组后主要资产为现金或者无具体经营业务的情形； （六）本次交易有利于上市公司在业务、资产、财务、人员、机构等方面与 实际控制人及其关联人保持独立，符合中国证监会关于上市公司独立性的相关规 定； （七）本次交易前，公司已按照《中华人民共和国公司法》《中华人民共和 国证券法》和中国证监会的有关要求，建立了相应的法人治理结构。本次交易完 成后，公司仍将严格按照法律、法规和规范性文件及《公司章程》的要求规范运 作，不断完善公司法人治理机构。本次交易有利于公司保持健全有效的法人治理 结构。 综上，本次交易符合《上市公司重大资产重组管理办法》第十一条规定。 深圳至正高分子材料股份有限公司（以下简称"上市公司"、"公司"）拟 通过重大资产置换、发行股份及支付现金的方式取得先进封装材料国际 ...

安徽富煌钢构股份有限公司（以下简称"上市公司"或"公司"）拟通过发 行股份及支付现金的方式向富煌建设、孟君、吕盼稂、富煌众发等 17 名交易对 方购买其合计持有的合肥中科君达视界技术股份有限公司 100.00%股份，并向不 超过 35 名特定投资者募集配套资金（以下合称"本次交易"）。 华泰联合证券有限责任公司（以下简称"本独立财务顾问"）系本次交易的 独立财务顾问。本独立财务顾问依照《上市公司重大资产重组管理办法》《上市 公司监管指引第 9 号——上市公司筹划和实施重大资产重组的监管要求》《公开 发行证券的公司信息披露内容与格式准则第 26 号——上市公司重大资产重组》 《上市公司并购重组财务顾问业务管理办法》及其他相关法规规范要求，就本次 交易相关事宜进行了尽职调查，对上市公司相关的申报和披露文件进行了审慎核 查。本独立财务顾问在充分尽职调查和内部审核的基础上作出以下承诺： （一）本独立财务顾问已按照规定履行尽职调查义务，有充分理由确信所发 表的专业意见与上市公司和交易对方披露的文件内容不存在实质性差异； 华泰联合证券有限责任公司 作为安徽富煌钢构股份有限公司独立财务顾问在充分尽职 调查和内核基础上出具的 ...

Core Viewpoint - The transaction involves Anhui Fuhuang Steel Structure Co., Ltd. acquiring 100% of Hefei Zhongke Junda Vision Technology Co., Ltd. through a combination of issuing shares and cash payments, with the involvement of 17 counterparties and fundraising from up to 35 specific investors [1][2]. Group 1 - The independent financial advisor, Huatai United Securities Co., Ltd., has confirmed that the parties involved in the transaction do not fall under the prohibitions outlined in the "Guidelines for the Supervision of Listed Companies No. 7" regarding abnormal trading related to major asset restructuring [1][2]. - As of the date of the verification opinion, there are no ongoing investigations or criminal prosecutions related to insider trading associated with this transaction among the relevant parties [1]. - There have been no administrative penalties or criminal responsibilities imposed by the China Securities Regulatory Commission in the past 36 months concerning insider trading related to major asset restructuring [1].

Core Viewpoint - The transaction proposed by Anhui Fuhuang Steel Structure Co., Ltd. involves acquiring 100% of Hefei Zhongke Junda Vision Technology Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds from specific investors [1] Group 1: Compliance with Regulations - The transaction complies with Article 11 of the Major Asset Restructuring Management Measures, ensuring that the asset pricing is fair and does not harm the company's or shareholders' legal rights [1] - The transaction meets the requirements of Article 43, confirming that there are no ongoing investigations or violations by the China Securities Regulatory Commission [1] - The transaction adheres to Article 44, indicating that there will be no significant adverse changes in financial status or unfair related transactions, and the company has adequately disclosed these aspects in the restructuring report [1] Group 2: Business Overview - Hefei Zhongke Junda Vision Technology Co., Ltd. specializes in innovative scientific instruments focused on high-speed visual perception and measurement technology, with its main business involving the research, production, and sales of high-speed image acquisition, analysis, and processing instruments and systems [1] - The target company does not belong to the same industry or supply chain as Anhui Fuhuang Steel Structure Co., Ltd., indicating a lack of significant synergy with the company's main business [1]

Core Viewpoint - The article discusses the significant asset restructuring between Haiguang Information Technology Co., Ltd. and Zhongke Shuguang Information Industry Co., Ltd., marking the first major asset restructuring under the newly revised regulations by the China Securities Regulatory Commission (CSRC) [1][4][6]. Group 1: Company Overview - Haiguang Information, listed on the Sci-Tech Innovation Board since August 12, 2022, focuses on the research, design, and sales of high-end processors for servers and workstations, with a total share capital of 2.32434 billion shares and a market capitalization of 316.41 billion yuan as of May 24, 2024 [2]. - Zhongke Shuguang, listed since November 6, 2014, specializes in high-end computers, storage, security, and data center products, with a total share capital of 1.4632 billion shares and a market capitalization of 90.57 billion yuan as of May 24, 2024 [2]. Group 2: Restructuring Details - The restructuring involves Haiguang Information absorbing Zhongke Shuguang through a share exchange, with the latter being the largest shareholder of the former, holding a 27.96% stake [1][2]. - The restructuring is significant as it is the first case following the CSRC's revised regulations, which aim to facilitate and simplify the process of major asset restructuring for listed companies [4][6]. Group 3: Regulatory Changes - The revised regulations include a mechanism for phased payment of shares for asset purchases, extending the registration decision validity to 48 months, and allowing for performance commitments to be fulfilled through either compensation or phased payments [4][5]. - The new rules also increase the tolerance for financial condition changes, related party transactions, and competition, aiming to enhance the independence of listed companies [5]. - A simplified review process for restructuring transactions has been introduced, allowing for quicker registration decisions by the CSRC [5].

数据来源：清科研究中心 郭晨凯 制图 ◎记者 王玉晴 "我最近跑了不少上市公司，他们很多都有并购需求，尤其是科技型上市公司。我们正在对公司已投企 业进行筛选，有合适的标的会推荐给他们。"5月22日，江苏乾融投资控股集团有限公司董事长叶晓明对 上海证券报记者说，在市场需求及政策松绑的双重推动下，各方寻找并购机会的兴趣都在明显增长。 记者采访了解到，创投机构参与并购的积极性正在提升。清科研究中心最新统计显示，4月并购类交易 退出数量继续呈同比上升趋势。今年一季度，并购类交易退出数量同比上升7.8%。 近两年，"退出难"成为创投行业面临的严峻考验，创投机构纷纷转向并购市场寻求退出机会。记者注意 到，今年以来，创投机构通过并购退出的数量有所增长，"退出难"问题得到一定疏解。 "春天来了！"有投资人对记者分析，中国证监会修改后的《上市公司重大资产重组管理办法》，建立了 重组股份对价分期支付机制、新设重组简易审核程序等，提升了创投机构参与并购的积极性。 创投机构以多种角色参与并购 5月20日，清科研究中心发布4月并购月报。4月PE/VC机构支持并购案例共有17笔，涉及并购金额为 91.59亿元。既有创投机构作为并购方（买 ...